000908 Share Price Performance
CN¥5.93
2.69 (83.02%)
Price CN¥5.93
Share PriceCN¥5.93
The Market Doesn't Like What It Sees From Hunan Jingfeng Pharmaceutical Co.,Ltd.'s (SZSE:000908) Revenues Yet As Shares Tumble 27%
Jun 13
Hunan Jingfeng Pharmaceutical Co.,Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
000908 Community Narratives
There are no narratives available yet.
Hunan Jingfeng Pharmaceutical Co.,Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 29, 2025
- Earnings per share (EPS)
- 0.17
- Gross Margin
- 64.89%
- Net Profit Margin
- 38.50%
- Debt/Equity Ratio
- -903.1%
Hunan Jingfeng Pharmaceutical Co.,Ltd. Competitors
Snowflake Analysis
About 000908
- Founded
- 2003
- Employees
- 547
- CEO
- WebsiteView website
Hunan Jingfeng Pharmaceutical Co.,Ltd. manufactures and sells chemical drugs and biological agents in China. The company’s principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmology and API products, as well as engages in the research and development of anti-tumor, cancer, and cardiovascular drugs; and provides skin care products. In addition, the company provides CDMO/CMO services. The company was founded in 2003 and is headquartered in Shanghai, China.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Chinese Market Performance
- 7 Days: 0.5%
- 3 Months: 17.0%
- 1 Year: 24.1%
- Year to Date: 26.2%
Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. As for the longer term, the market has risen 24% in the past 12 months. Earnings are forecast to grow by 27% annually. Market details ›